BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8238797)

  • 21. Insect venom allergy: a prospective case study showing lack of correlation between immunologic reactivity and clinical sensitivity.
    Reisman RE; Lazell M; Doerr J
    J Allergy Clin Immunol; 1981 Nov; 68(5):406-8. PubMed ID: 7299004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow jacket allergy. Comparison of skin prick tests and intradermal tests with three different yellow jacket venom extracts.
    Jeep S; Reiprich G; Kunkel G
    Allergy; 1992 Feb; 47(1):35-40. PubMed ID: 1590565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reassessing the role of hyaluronidase in yellow jacket venom allergy.
    Jin C; Focke M; Léonard R; Jarisch R; Altmann F; Hemmer W
    J Allergy Clin Immunol; 2010 Jan; 125(1):184-90.e1. PubMed ID: 19910026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between two different assays for measurements of allergen-specific IgE and skin prick test in the diagnosis of insect venom allergy.
    Eiken P; Mosbech H; Jacobsen L; Larsen P; Scharling B; Svendsen UG; Søes-Petersen U
    Allergy; 1992 Oct; 47(5):495-7. PubMed ID: 1485652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy.
    Blaauw PJ; Smithuis OL; Elbers AR
    J Allergy Clin Immunol; 1996 Jul; 98(1):39-47. PubMed ID: 8765816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.
    Bilò MB; Severino M; Cilia M; Pio A; Casino G; Ferrarini E; Campodonico P; Milani M
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):57-61. PubMed ID: 19663128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the venom immunogenicity of various species of yellow jackets (genus Vespula).
    Wicher K; Reisman RE; Wypych J; Elliott W; Steger R; Mathews RS; Arbesman CE
    J Allergy Clin Immunol; 1980 Sep; 66(3):244-9. PubMed ID: 6774004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors.
    Birnbaum J; Ramadour M; Magnan A; Vervloet D
    Clin Exp Allergy; 2003 Jan; 33(1):58-64. PubMed ID: 12534550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Component-resolved diagnosis of wasp (yellow jacket) venom allergy.
    Ebo DG; Faber M; Sabato V; Leysen J; Bridts CH; De Clerck LS
    Clin Exp Allergy; 2013 Feb; 43(2):255-61. PubMed ID: 23331567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergens in hymenoptera venom. VI. Cross reactivity of human IgE antibodies to the three vespid venoms and between vespid and paper wasp venoms.
    Hoffman DR
    Ann Allergy; 1981 Jun; 46(6):304-9. PubMed ID: 7247080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of sensitivity to Hymenoptera venom in 200 allergic patients followed for up to 3 years.
    Bousquet J; Knani J; Velasquez G; Menardo JL; Guilloux L; Michel FB
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):944-50. PubMed ID: 2600326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of bee sting allergy by skin tests and serum antibody assays.
    Miyachi S; Lessof MH; Kemeny DM
    Int Arch Allergy Appl Immunol; 1979; 60(2):148-53. PubMed ID: 468389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy.
    Scherer K; Weber JM; Jermann TM; Krautheim A; Tas E; Ueberschlag EV; Cammarata M; Bircher AJ
    Int Arch Allergy Immunol; 2008; 146(2):122-32. PubMed ID: 18204278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venom skin testing and alteration of RAST levels.
    Schuller DE; Sutton PL
    Ann Allergy; 1981 Aug; 47(2):84-6. PubMed ID: 7258743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of skin tests and RAST for the diagnosis of bee sting allergy.
    Patrizzi R; Müller U; Yman L; Hoigné R
    Allergy; 1979 Aug; 34(4):249-56. PubMed ID: 517710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy.
    Randolph CC; Reisman RE
    J Allergy Clin Immunol; 1986 Jun; 77(6):823-7. PubMed ID: 3711549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment.
    Thurnheer U; Müller U; Stoller R; Lanner A; Hoigné R
    Allergy; 1983 Oct; 38(7):465-75. PubMed ID: 6638413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evolution of in vivo and in vitro tests during specific immunotherapy against hymenoptera venoms].
    Sabbah A; Heulin MG; Soulière I
    Allerg Immunol (Paris); 1990 Jun; 22(6):242-7. PubMed ID: 1696102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
    Sturm G; Kränke B; Rudolph C; Aberer W
    J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin and radioallergosorbent tests in patients with sensitivity to bee and wasp venom.
    Harries MG; Kemeny DM; Youlten LJ; Mills MM; Lessof MH
    Clin Allergy; 1984 Sep; 14(5):407-12. PubMed ID: 6488511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.